Related Experiment Video

Updated: Aug 19, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

A prospective study of visceral leishmaniasis in an endemic area of Brazil

R Badaró, T C Jones, R Lorenço

    The Journal of Infectious Diseases
    |October 1, 1986
    PubMed

    Insights

    Visceral leishmaniasis affects 3.1% of children in Brazil, with young age and malnutrition as key risk factors. Early diagnosis and treatment are crucial for managing this parasitic disease.

    Area of Science:

    • Tropical medicine
    • Infectious diseases
    • Parasitology

    Background:

    • Visceral leishmaniasis is a significant public health concern in endemic regions.
    • Understanding its epidemiology and risk factors is crucial for effective control.

    Purpose of the Study:

    • To prospectively investigate the epidemiology, clinical features, and risk factors of visceral leishmaniasis in Brazilian children.
    • To determine the ratio of infection to disease and the impact of early diagnosis.

    Main Methods:

    • Prospective study in a Brazilian endemic area.
    • Surveillance of disease prevalence and incidence in children.
    • Serological testing for Leishmania infection.
    • Analysis of risk factors including age and nutritional status.

    Main Results:

    • Disease prevalence was 3.1% in children under 15; annual incidence was 4.3 cases per 1,000.
    • Young age (median 3 years) and malnutrition were identified as primary risk factors.
    • The infection-to-disease ratio was 1:18.5 overall, and 1:6.5 in high-prevalence areas.
    • Early diagnosis and therapy modified clinical presentation.

    Conclusions:

    • Visceral leishmaniasis exhibits fluctuating patterns and varied distribution in endemic areas.
    • Malnutrition and young age significantly increase disease risk in children.
    • The study highlights the importance of early detection and intervention for better patient outcomes.

    More Related Videos

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    In Vivo Imaging of Leishmania infantum-infected Hamsters by Gingival Inoculation of Axenic Amastigotes Expressing Luciferase05:55

    In Vivo Imaging of Leishmania infantum-infected Hamsters by Gingival Inoculation of Axenic Amastigotes Expressing Luciferase

    Published on: April 4, 2025

    Related Concept Videos

    Leishmaniasis01:30

    Leishmaniasis

    Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
    American Trypanosomiasis01:22

    American Trypanosomiasis

    Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...